tiprankstipranks
Advertisement
Advertisement

NRSN Stock Latest News

NeuroSense Reschedules Health Canada Meeting as PrimeC Data Package Strengthens
Company AnnouncementsNeuroSense Reschedules Health Canada Meeting as PrimeC Data Package Strengthens
3d ago
6K
NRSN
Neurosense Therapeutics Ltd. (NRSN) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Neurosense Therapeutics Ltd. (NRSN) Q4 Earnings Cheat Sheet
4d ago
NRSN
NeuroSense’s ALS Drug PrimeC Shows Strong Phase 2b Results in JAMA Neurology
PremiumCompany Announcements
NeuroSense’s ALS Drug PrimeC Shows Strong Phase 2b Results in JAMA Neurology
11d ago
6K
NRSN
NeuroSense Shareholders Approve Increase in Registered Share Capital
PremiumCompany Announcements
NeuroSense Shareholders Approve Increase in Registered Share Capital
16d ago
6K
NRSN
NeuroSense initiated with a Buy at Roth Capital
PremiumThe Fly
NeuroSense initiated with a Buy at Roth Capital
17d ago
NRSN
NeuroSense Reports 65% Lower Mortality Risk and 14-Month Survival Gain for PrimeC in ALS Trial
PremiumCompany AnnouncementsNeuroSense Reports 65% Lower Mortality Risk and 14-Month Survival Gain for PrimeC in ALS Trial
1M ago
6K
NRSN
NeuroSense reports additional long-term survival data from PARADIGM 2b trial
Premium
The Fly
NeuroSense reports additional long-term survival data from PARADIGM 2b trial
1M ago
NRSN
NeuroSense Therapeutics Calls March 10, 2026 Special Meeting to Approve Share Capital Increase
Premium
Company Announcements
NeuroSense Therapeutics Calls March 10, 2026 Special Meeting to Approve Share Capital Increase
1M ago
6K
NRSN
NeuroSense Wins Australian Patent to Extend PrimeC IP Protection Through 2042
PremiumCompany Announcements
NeuroSense Wins Australian Patent to Extend PrimeC IP Protection Through 2042
2M ago
6K
NRSN
NeuroSense granted Australian patent covering PrimeC composition
PremiumThe Fly
NeuroSense granted Australian patent covering PrimeC composition
2M ago
NRSN
NeuroSense files $150M mixed securities shelf
PremiumThe Fly
NeuroSense files $150M mixed securities shelf
2M ago
NRSN
NeuroSense Shareholders Approve Equity Grants to Directors and CEO to Preserve Cash
PremiumCompany Announcements
NeuroSense Shareholders Approve Equity Grants to Directors and CEO to Preserve Cash
3M ago
6K
NRSN
NeuroSense Reports Favorable Safety Profile for PrimeC in Phase 2 Alzheimer’s Trial
PremiumCompany AnnouncementsNeuroSense Reports Favorable Safety Profile for PrimeC in Phase 2 Alzheimer’s Trial
3M ago
6K
NRSN
NeuroSense confirms favorable safety, tolerability of Prime C in Phase 2 study
Premium
The Fly
NeuroSense confirms favorable safety, tolerability of Prime C in Phase 2 study
3M ago
NRSN
NeuroSense Completes Data Collection for Alzheimer’s Trial
Premium
Company Announcements
NeuroSense Completes Data Collection for Alzheimer’s Trial
4M ago
6K
NRSN
NeuroSense Therapeutics Plans Pre-NDS Meeting with Health Canada for ALS Drug
PremiumCompany Announcements
NeuroSense Therapeutics Plans Pre-NDS Meeting with Health Canada for ALS Drug
4M ago
6K
NRSN
NeuroSense Gains FDA Approval for Phase 3 ALS Trial
PremiumCompany Announcements
NeuroSense Gains FDA Approval for Phase 3 ALS Trial
4M ago
6K
NRSN
NeuroSense reports FDA clearance to initiate Phase 3 trial for PrimeC in ALS
PremiumThe Fly
NeuroSense reports FDA clearance to initiate Phase 3 trial for PrimeC in ALS
4M ago
NRSN
NRSN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
NRSN Earnings this Week: How Will it Perform?
4M ago
NRSN
NeuroSense Therapeutics Schedules Shareholder Meeting to Approve Equity Compensation
PremiumCompany AnnouncementsNeuroSense Therapeutics Schedules Shareholder Meeting to Approve Equity Compensation
4M ago
6K
NRSN
NeuroSense files to sell 333K ordinary shares for holders
Premium
The Fly
NeuroSense files to sell 333K ordinary shares for holders
5M ago
NRSN
NeuroSense initiated with an Outperform at Noble Capital
Premium
The Fly
NeuroSense initiated with an Outperform at Noble Capital
5M ago
NRSN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >